Key Financial Data Of Group

Delta-Fly Pharma, Inc. - Filing #7710878

Concept	As at 2019-03-31	2018-04-01 to 2019-03-31	As at 2018-03-31	2017-04-01 to 2018-03-31	2016-04-01 to 2017-03-31	As at 2017-03-31	2015-04-01 to 2016-03-31	As at 2016-03-31	2014-04-01 to 2015-03-31	As at 2015-03-31
Key financial data of group
Business results of group
Ordinary profit (loss)	—	-671,213,000 JPY	—	-244,505,000 JPY	323,286,000 JPY	—	-595,588,000 JPY	—	-288,020,000 JPY	—
Net assets	3,504,107,000 JPY	—	822,493,000 JPY	—	—	768,762,000 JPY	—	463,656,000 JPY	—	631,198,000 JPY
Total assets	3,567,363,000 JPY	—	864,145,000 JPY	—	—	968,229,000 JPY	—	709,410,000 JPY	—	845,895,000 JPY
Net assets per share	801.93	—	228.15	—	—	222.51	—	134.20	—	208.66
Basic earnings (loss) per share	—	-170.16	—	-71.20	88.31	—	-185.53	—	-127.65	—
Diluted earnings per share	—		—			—		—		—
Equity-to-asset ratio	0.982 xbrli:pure	—	0.952 xbrli:pure	—	—	0.794 xbrli:pure	—	0.654 xbrli:pure	—	0.746 xbrli:pure
Rate of return on equity	—	xbrli:pure	—	xbrli:pure	0.495 xbrli:pure	—	xbrli:pure	—	xbrli:pure	—
Price-earnings ratio	—	xbrli:pure	—	xbrli:pure	xbrli:pure	—	xbrli:pure	—	xbrli:pure	—
Net cash provided by (used in) operating activities	—	-585,385,000 JPY	—	100,042,000 JPY	-251,582,000 JPY	—	JPY	—	JPY	—
Net cash provided by (used in) investing activities	—	-3,544,000 JPY	—	JPY	-1,020,000 JPY	—	JPY	—	JPY	—
Net cash provided by (used in) financing activities	—	3,316,882,000 JPY	—	292,724,000 JPY	-6,792,000 JPY	—	JPY	—	JPY	—
Cash and cash equivalents	3,508,437,000 JPY	—	781,250,000 JPY	—	—	387,885,000 JPY	—	JPY	—	JPY
Number of employees	11 xbrli:pure	—	11 xbrli:pure	—	—	8 xbrli:pure	—	5 xbrli:pure	—	5 xbrli:pure
Average number of temporary employees	xbrli:pure	—	xbrli:pure	—	—	xbrli:pure	—	2 xbrli:pure	—	xbrli:pure